[go: up one dir, main page]

AU2001251665A1 - Medicine response assay in respiratory disease - Google Patents

Medicine response assay in respiratory disease

Info

Publication number
AU2001251665A1
AU2001251665A1 AU2001251665A AU5166501A AU2001251665A1 AU 2001251665 A1 AU2001251665 A1 AU 2001251665A1 AU 2001251665 A AU2001251665 A AU 2001251665A AU 5166501 A AU5166501 A AU 5166501A AU 2001251665 A1 AU2001251665 A1 AU 2001251665A1
Authority
AU
Australia
Prior art keywords
respiratory disease
response assay
medicine response
medicine
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251665A
Inventor
Wayne H. Anderson
Lisa D. Edwards
Amanda H. Emmett
Sreekumar Pillai
Catherine S. Sprankel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001251665A1 publication Critical patent/AU2001251665A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001251665A 2000-04-17 2001-04-17 Medicine response assay in respiratory disease Abandoned AU2001251665A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19791300P 2000-04-17 2000-04-17
US60/197,913 2000-04-17
US23660800P 2000-09-29 2000-09-29
US60/236,608 2000-09-29
PCT/US2001/012534 WO2001079560A2 (en) 2000-04-17 2001-04-17 Medicine response assay in respiratory disease

Publications (1)

Publication Number Publication Date
AU2001251665A1 true AU2001251665A1 (en) 2001-10-30

Family

ID=26893274

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251665A Abandoned AU2001251665A1 (en) 2000-04-17 2001-04-17 Medicine response assay in respiratory disease

Country Status (6)

Country Link
US (1) US6939674B2 (en)
EP (1) EP1276906A2 (en)
JP (1) JP2003530844A (en)
AU (1) AU2001251665A1 (en)
CA (1) CA2406090A1 (en)
WO (1) WO2001079560A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4365099B2 (en) 2001-04-20 2009-11-18 ノボザイムス アクティーゼルスカブ Lipoxygenase
US6897025B2 (en) * 2002-01-07 2005-05-24 Perlegen Sciences, Inc. Genetic analysis systems and methods
WO2006010103A1 (en) * 2004-07-07 2006-01-26 Wisconsin Alumni Research Foundation Genetic predictor of efficacy of anti-asthmatic agents for improving pulmonary function
US7811765B2 (en) * 2006-10-12 2010-10-12 Children's Hospital & Research Center At Oakland Methods and compositions for determining predisposition to inflammation-mediated cardiovascular disease
JP2010527246A (en) * 2007-05-18 2010-08-12 バイオリポックス エービー Method
EP4008327A1 (en) 2009-04-29 2022-06-08 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
US20150005382A1 (en) * 2011-10-04 2015-01-01 Wake Forest University Health Sciences (WFUHS) Methods for Identifying and Treating an Individual with an Inflammatory Disease using Fatty Acid-Based Therapies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0896633A2 (en) * 1996-05-06 1999-02-17 Brigham And Women's Hospital 5-lipoxygenase gene polymorphisms and their use in classifying patients
GB9717766D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Methods
US6334099B1 (en) * 1999-05-25 2001-12-25 Digital Gene Technologies, Inc. Methods for normalization of experimental data

Also Published As

Publication number Publication date
WO2001079560A3 (en) 2002-10-17
US6939674B2 (en) 2005-09-06
EP1276906A2 (en) 2003-01-22
CA2406090A1 (en) 2001-10-25
JP2003530844A (en) 2003-10-21
WO2001079560A2 (en) 2001-10-25
US20030162193A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
AU2001244188A1 (en) Medicaments against viral diseases
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2001269508A1 (en) Drugs or cosmetics
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
AU2002221099A1 (en) Combination drugs
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001251665A1 (en) Medicine response assay in respiratory disease
AU2001232244A1 (en) Drug comprising combination
AU2001270129A1 (en) Human phosphodiesterases
AU2001261552A1 (en) Disposable respirator
IL151019A0 (en) Microcompetition and human disease
AU2001282527A1 (en) Antiparkinsonism drugs
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use
AU2001286575A1 (en) 15985, a human serine/threonine protein kinase family member and uses thereof
AU2001297710A1 (en) Integrated drug development techniques
AU2001258569A1 (en) Alzheimer's disease assay
AU2001295337A1 (en) E. histolytica-specific antibodies and clinical uses thereof
AU2001278130A1 (en) 57250, a human sugar transporter family member and uses thereof
AU2001219899A1 (en) Medicine ball
GB9907234D0 (en) Drug assay
AU2001272552A1 (en) Oxygen-enriched agent and the use thereof for therapeutic purposes
AU2001290565A1 (en) Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof